December 28, 2014 8:30 PM ET

Pharmaceuticals

Company Overview of TAXIS Pharmaceuticals, Inc.

Executive Profile

Christopher M. Cimarusti Ph.D.

Advisor and Director, TAXIS Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
70--

Background

Dr. Christopher M. Cimarusti, also known as Chris, Ph.D., serves as Advisor of TAXIS Pharmaceuticals, Inc. Dr. Cimarusti is a Consultant with broad experience in pharmaceutical discovery, development and manufacturing. Dr. Cimarusti served as Vice President of Process R&D within the Pharmaceutical Research Institute. In 1998, Dr. Cimarusti served as Senior Vice President of Pharmaceutical Development and led a global staff of 1200 engaged in the CMC disciplines for small ...

Corporate Headquarters

675 US Highway 1
North Brunswick, New Jersey 08902

United States

Phone: 732-729-6230
Fax: --

Board Members Memberships

Advisor and Director
2009-Present
Non-Executive & Non-Independent Director

Education

Master's Degree
Columbia University
PhD
Purdue University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAXIS Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.